Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study.
Bor WL, de Veer AJW, Olie RH, Rikken SAOF, Chan Pin Yin DRPP, Herrman JPR, Vrolix M, Meuwissen M, Vandendriessche T, van Mieghem C, Magro M, Bennaghmouch N, Hermanides R, Adriaenssens T, Dewilde WJM, Ten Berg JM. Bor WL, et al. Among authors: vandendriessche t. EuroIntervention. 2022 Jul 22;18(4):e303-e313. doi: 10.4244/EIJ-D-21-00703. EuroIntervention. 2022. PMID: 35370126 Free PMC article.
Cost-effectiveness of contemporary vascular closure devices for the prevention of vascular complications after percutaneous coronary interventions in an all-comers PCI population.
Kerré S, Kustermans L, Vandendriessche T, Bosmans J, Haine SE, Miljoen H, Vrints CJ, Beutels P, Wouters K, Claeys MJ. Kerré S, et al. Among authors: vandendriessche t. EuroIntervention. 2014 Jun;10(2):191-7. doi: 10.4244/EIJV10I2A32. EuroIntervention. 2014. PMID: 24952056 Free article.
Failed Downregulation of Circulating MicroRNA-155 in the Early Phase after ST Elevation Myocardial Infarction Is Associated with Adverse Left Ventricular Remodeling.
Latet SC, Van Herck PL, Claeys MJ, Van Craenenbroeck AH, Haine SE, Vandendriessche TR, Van Hoof VO, Fransen E, De Winter BY, Van Craenenbroeck EM, Heidbuchel H, Vrints CJ, Hoymans VY. Latet SC, et al. Cardiology. 2017;138(2):91-96. doi: 10.1159/000477235. Epub 2017 Jun 16. Cardiology. 2017. PMID: 28618412
Comparison of radial access versus femoral access with the use of a vascular closure device for the prevention of vascular complications and mortality after percutaneous coronary intervention.
Téblick A, Vanderbruggen W, Vandendriessche T, Bosmans J, Haine SEF, Miljoen H, Segers V, Wouters K, Vrints C, Claeys MJ. Téblick A, et al. Among authors: vandendriessche t. Acta Cardiol. 2018 Jun;73(3):241-247. doi: 10.1080/00015385.2017.1363947. Epub 2017 Aug 29. Acta Cardiol. 2018. PMID: 28851255
Assessing the landscape of percutaneous coronary chronic total occlusion treatment in Belgium and Luxembourg: the Belgian Working Group on Chronic Total Occlusions (BWGCTO) registry.
Maeremans J, Kayaert P, Bataille Y, Bennett J, Ungureanu C, Haine S, Vandendriessche T, Sonck J, Scott B, Coussement P, Dendooven D, Pereira B, Frambach P, Janssens L, Debruyne P, Van Mieghem C, Barbato E, Cornelis K, Stammen F, De Vroey F, Vercauteren S, Drieghe B, Aminian A, Debrauwere J, Carlier S, Coosemans M, Van Reet B, Vandergoten P, Dens JA; (On behalf of the BWGCTO Investigators). Maeremans J, et al. Among authors: vandendriessche t. Acta Cardiol. 2018 Oct;73(5):427-436. doi: 10.1080/00015385.2017.1408891. Epub 2017 Nov 28. Acta Cardiol. 2018. PMID: 29183248
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention.
de Veer AJWM, Bennaghmouch N, Bor WL, Herrman JPR, Vrolix M, Meuwissen M, Vandendriessche T, Adriaenssens T, de Bruyne B, Magro M, Dewilde WJM, Ten Berg JM. de Veer AJWM, et al. Among authors: vandendriessche t. Neth Heart J. 2022 Jun;30(6):302-311. doi: 10.1007/s12471-022-01664-0. Epub 2022 Mar 1. Neth Heart J. 2022. PMID: 35230636 Free PMC article.
Adiponectin and ischemia-reperfusion injury in ST segment elevation myocardial infarction.
De Roeck L, Vandamme S, Everaert BR, Hoymans V, Haine S, Vandendriessche T, Bosmans J, Ronsyn MW, Miljoen H, Van Berendoncks A, De Meyer G, Vrints C, Claeys MJ. De Roeck L, et al. Among authors: vandendriessche t. Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):71-6. doi: 10.1177/2048872615570770. Epub 2015 Feb 26. Eur Heart J Acute Cardiovasc Care. 2016. PMID: 25722457
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
182 results